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a  b  s  t  r  a  c  t
Antimicrobials  are  an  effective  treatment  for  many  types  of  infections,  but their  overuse  promotes  the
spread  of  resistant  microorganisms  that  defy  conventional  treatments  and  complicate  patient  care.  In
2009,  an  antimicrobial  stewardship  program  was  implemented  at Mount  Sinai  Hospital  (MSH,  Toronto,
Canada).  Components  of  this  program  were  to  alter  the  fraction  of  patients  prescribed  antimicrobials,
to  shorten  the  average  duration  of  treatment,  and to  alter the  types  of  antimicrobials  prescribed.  These
components  were  incorporated  into  a mathematical  model  that  was  compared  to data  reporting  the
number  of  patients  colonized  with  Pseudomonas  aeruginosa  and  the  number  of patients  colonized  with
antimicrobial-resistant  P.  aeruginosa  ﬁrst  isolates  before  and  after  the  antimicrobial  stewardship  pro-
gram.  Our  analysis  shows  that the reported  decrease  in the  number  of patients  colonized  was  due  to
treating fewer  patients,  while  the  reported  decrease  in the  number  of patients  colonized  with  resis-
tant  P. aeruginosa  was  due  to the  combined  effect  of  treating  fewer  patients  and  altering  the types  ofnappropriate prescribing antimicrobials  prescribed.  We  also  ﬁnd  that  shortening  the average  duration  of treatment  was  unlikely
to have  produced  any  noticeable  effects  and that  further  reducing  the  fraction  of  patients  prescribed
antimicrobials  would  most  substantially  reduce  P. aeruginosa  antimicrobial  resistance  in  the  future.  The
analytical  framework  that  we  derive  considers  the  effect  of  colonization  pressure  on  infection  spread  and
can be  used  to interpret  clinical  antimicrobial  resistance  data  to assess  different  aspects  of  antimicrobial
cologstewardship  within  the  e
ntroduction
The introduction of antimicrobial agents for the treatment
f serious bacterial infections is one of the major biomedical
dvances of the last century. However, gains in health and life-years
ssociated with antimicrobials have been progressively eroded
n recent decades by the ongoing emergence of antimicrobial-
esistant organisms (ARO), with an increasing fraction of serious
nfections caused by multidrug-resistant organisms (Cardo et al.,
004; Paterson et al., 2005; Jones et al., 2009, 2010). This prob-
em has become particularly severe in the healthcare setting in
eneral, and in the intensive care unit (ICU) environment in par-
icular, where several factors combine to give resistant pathogens
Abbreviations: ARO, antimicrobial-resistant organisms; ICU, intensive care unit;
SH, Mount Sinai Hospital.
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a strong competitive advantage (Weber et al., 1999; Vincent, 2003).
Key among these is the selective advantage conferred upon ARO in
patients who are heavily exposed to antimicrobial agents (Weber
et al., 1999; Oosdijk et al., 2009). In addition, the use (both necessary
and unnecessary) of broad-spectrum antimicrobials in vulnerable
patient populations increases these patients’ susceptibility to colo-
nization and invasive infection with pathogens (Bonten et al., 1999;
Safdar and Maki, 2002; Thuong et al., 2003; Boyer et al., 2011).
Non-lactose fermenting gram-negative microbes, such as Pseu-
domonas aeruginosa have been particularly adept at acquiring
resistance to multiple antimicrobial classes. Mechanisms of resis-
tance commonly encountered in P. aeruginosa include efﬂux pumps,
production of enzymes that inactivate antimicrobials, mutation of
antimicrobial target sites, and reduced permeability to antimicro-
bials (Sun et al., 2011). The propensity for antimicrobial resistance
displayed by P. aeruginosa is particularly concerning given the
high level of virulence of this microbe, especially in patients with
indwelling devices, on mechanical ventilation (Thuong et al., 2003),
or with anatomical or immune differences due to such illnesses
as cystic ﬁbrosis, burns or HIV infection (Gustafsson and Martínez,
2 idemics 4 (2012) 203–210
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Table 1
List of assumptions.
(i) Antimicrobial treatment does not eradicate P. aeruginosa colonization
(ii) The transmission rate is the same for all patients (whether colonized,
infected, or receiving treatment) and does not depend on the P.
aeruginosa clone’s susceptibility to antimicrobials
(iii) Superinfection does not occur
(iv) P. aeruginosa transmission occurs via healthcare workers and
healthcare workers acquire P. aeruginosa contamination in the ICU
(v)  All infected patients are prescribed an antimicrobial that the infecting
P. aeruginosa clone is susceptible to. When receiving an antimicrobial,
resistance emerges at a constant rate which is the same for both
colonized and infected patients
(vi) The treatment status of patients remains unchanged when they
become colonized
(vii) The rate of ending treatment for all colonized (and infected) patients
is the same regardless of whether the patient was  treated when
uncolonized (or colonized)
(viii) Ceftazidime, ciproﬂoxacin and meropenem are never prescribed in
combination
(ix)  The rate of discharge is independent of the patient’s status (i.e., if the04 A. Hurford et al. / Ep
005). Efforts to reduce the prevalence of resistance in P. aeruginosa
nd other pathogens often focus on strategies that alter the selec-
ive pressure created via antimicrobial exposure. These strategies
nclude antimicrobial cycling or mixing (Sandiumenge et al., 2006)
nd aggressive ‘stewardship’ of antimicrobial resources that limit
he duration and intensity of antimicrobial exposure (Shlaes et al.,
997; Dellit et al., 2007). Furthermore, frequently multiple inter-
entions are implemented simultaneously making it difﬁcult to
ssess the effect due to any one intervention (Dellit et al., 2007).
To describe the effects of different aspects of an antimicrobial
tewardship program, we  derive a mathematical model that relates
ntimicrobial prescribing to the prevalence of antimicrobial resis-
ance. The model is compared to data from the Mount Sinai Hospital
MSH) ICU reporting the prevalence of antimicrobial resistance
efore and after the implementation of an antimicrobial steward-
hip program in February 2009. We  consider each of three different
spects of the antimicrobial stewardship program and characterize
he contribution of each to the reported declines in the number of
atients colonized with P. aeruginosa and the prevalence of antimi-
robial resistance among ﬁrst isolates. Finally, we identify which
f three different aspects of antimicrobial stewardship would most
ubstantially reduce the prevalence of antimicrobial resistance in
he future.
ethods
During each six-month period from October 2005 to October
011, the number of patients colonized and the number of ﬁrst P.
eruginosa isolates resistant to different antipseudomonal antimi-
robials was recorded (‘ﬁrst isolate’ refers to the earliest recovered
ample given that the same patient may  be sampled multiple
imes). We  express these recorded quantities in terms of their
ontributing epidemiological processes. The rate of change in the
umber of patients colonized, C, is the sum of the rate that patients
re admitted colonized, and the rate that patients become colonized
n the ICU,
˙ = mN + ˇ(XT + XA)(S + R). (1)
ere, patients are admitted to the ICU per bed at a rate  and dis-
harged at the same rate to maintain a ﬁxed number, N, of patients
n the ICU at all times. The fraction of patients that are admitted
olonized is m. Uncolonized patients that are receiving, XT, or have
eceived antimicrobials, XA, are susceptible to P. aeruginosa col-
nization, and the transmission of P. aeruginosa occurs at a rate
(S + R) per patient susceptible to colonization. The number of
atients colonized or infected with antimicrobial-susceptible and
ntimicrobial-resistant P. aeruginosa (S and R, respectively) con-
ributes to the total colonization pressure, S + R. Each of XT, XA, S and
 are dynamic variables that are interdependent and inﬂuenced by
he ecology of the ICU as fully described in the mathematical model
Eqs. (A.1)–(A.14)).
To relate Eq. (1) to the MSH  clinical data, the number of patients
hat were colonized while in the ICU during a six-month period is
 =
∫ 365/2
0
C˙ dt. This integral is approximated as,
 ≈ 365
2
(mN + ˇ(XˆT + XˆA)(Sˆ + Rˆ)), (2)
here XˆT , XˆA, Sˆ,  and Rˆ  denote the equilibrium values of each
ynamic variable and where the validity of this approximation
s discussed in Appendix A. For patients who carry resistant P.
eruginosa, the clinical data distinguishes between P. aeruginosa
lones that are resistant to ceftazidime (i = 1), ciproﬂoxacin (i = 2),
nd meropenem (i = 3) and clones resistant to two antimicro-
ials are denoted by the ij subscript. For simplicity, we  model
nly resistance to these three antimicrobials as the P. aeruginosapatient is uncolonized, colonized or infected)
isolates from MSH  were highly susceptible to tobramycin and
piperacillin-tazobactam (with median susceptibilities of 89% and
93%). Resistance to all three antimicrobials was not considered for
simplicity and because triple-resistant mutants are less common.
Let Ri, Ri× and Rij be the number of patients with ﬁrst isolates
resistant to the antimicrobial i, the antimicrobial i only, and the
antimicrobials i and j recorded over the six-month period. Then,
Ri ≈ Ri× +
∑
j
Rij, (3)
where,
Ri× ≈
365
2
(rimN  + ˇ(XˆT + XˆA)Rˆi, (4)
Rij ≈
365
2
ˇ(XˆT + XˆA)Rˆij. (5)
For simplicity, Eq. (5) assumes that no patients are admitted colo-
nized with P. aeruginosa clones that are resistant to more than one
antimicrobial.
The effect of antimicrobial stewardship on patient colonization
and resistance occurs through the affect of stewardship on the val-
ues of XˆT , XˆA, Sˆ and Rˆ. These relationships are shown in Fig. 1 and
described in Appendix A (Eqs. (A.1)–(A.14)). The assumptions of the
model formulation (Eqs. (A.1)–(A.14)) are listed in Table 1 and these
assumptions were made either to simply or to accurately reﬂect the
ecology of P. aeruginosa spread.
The changes in antimicrobial prescribing arising from the
antimicrobial stewardship program can be summarized as having
three effects that are described by the model parameters 0, 1
and the ωis (Fig. 1B). In practice, the antimicrobial stewardship
program at MSH  consisted of a collaborative daily review of all
patients during which members of the antimicrobial stewardship
program team advised the ICU team on antimicrobial use, primarily
on the basis of antimicrobial efﬁcacy and drug safety (i.e., toxic-
ity), but where subsequent considerations included using therapies
targeted to known pathogens (rather than unnecessarily broad-
spectrum or antipseudomonal antimicrobials), reducing costs, and
reducing the duration of treatment from 11–12 days to 8 days. In
terms of the mathematical model (Eqs. (A.1)–(A.14)), one effect of
the antimicrobial stewardship program is to have altered the frac-
tion of uninfected patients that were prescribed antimicrobials (FP).
This fraction is approximated as 0/(0 + ) (see Appendix A) and
the reference to ‘uninfected patients’ in the context of the model
means ‘without a P. aeruginosa infection’. A second effect is that
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Fewer uninfected patients are
prescribed antimicrobials (FP)
The duration of treatment is
shortened (SD)
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Fig. 1. The number of ICU patients that are uncolonized, colonized, infected or have experienced a treatment failure and the susceptibility of P. aeruginosa clones to
antimicrobials depends on patient admission, colonization, infection, antimicrobial treatments and the emergence of resistance. The mathematical model (Eqs. (A.1)–(A.14))
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opinion, while general parameters were estimated from the pub-s  depicted in (A) (patient discharge is not shown). Different aspects of the antimicr
hat  patients transition from one state to another as shown in (B).
fter the implementation of the antimicrobial stewardship pro-
ram, the duration of antimicrobial treatment, 1/1, was shortened
SD). Finally, the third effect is that the antimicrobial stewardship
rogram may  have facilitated a shift to using alternative types of
ntimicrobials (AT). This change is represented in the mathematical
odel (Eqs. (A.1)–(A.14)) as a change in the probability of pre-
cribing ceftazidime, ciproﬂoxacin, and meropenem to uninfected
atients (ω1, ω2 and ω3).
The predictions of the mathematical model, C, R1, R2, and R3
Eqs. (2) and (3))  can be compared to the analogous quantities
eported in the MSH  data, C
+
, C
−
, R
+
i and R
−
i , where the super-
cripts denote before (+) and after (−) the implementation of the
ntimicrobial stewardship program and where the bar denotes that
 mean was taken over several six-month periods. The superscripts
eﬂect that for MSH  these mean values, after the antimicrobial
tewardship program, were less than before such that C
−
< C
+
and
−
i < R
+
i for all i.
ariability in the data
The number of patients colonized, and the number of patients
olonized with resistant P. aeruginosa,  for each six-month period
eported in the data is highly variable. Such variability is likely due
o chance events and given this stochasticity the parameters in the
athematical model should be interpreted as means (i.e., the mean
ransmission rate is  ˇ and chance events that are not explicitly
odelled may  produce variability around this mean). Furthermore,stewardship program would decrease (dashed line) or increase (thick line) the rate
the ordinary differential equation model that we derive treats the
number of patients in each state as a continuous variable rather
than treating the number of patients in each state as a discrete
quantity that takes on integer values between zero and N. A poten-
tial inaccuracy may  arise given that under the continuous variable
formulation the colonization pressure, S + R, is never equal to zero
(given a positive initial condition), while in a real ICU, at some point
in time it may  happen that no patients are colonized or infected. To
justify the formulation of the mathematical model with continuous
state variables, we note that P. aeruginosa can persist on equipment
and in the environment, and so, in practice, even when no patients
are colonized there is still a small risk that patients in the ICU will
become colonized.
Parameter estimation
The mathematical model was  parameterized using data
reported in the published literature, from expert knowledge, and
by comparing the predictions of the mathematical model for differ-
ent parameter values with the data from MSH  (Table 2). Parameters
that were unknown but speciﬁc to MSH  were estimated from expertlished literature (these calculations are provided in Appendix A).
The remaining parameters ri, m,  and ˇ, and the unknown param-
eters related to the effect of antimicrobial stewardship, 0 and ωi,
were estimated from the MSH  data (Fig. 2).
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Table 2
Parameter estimates.
Parameter Deﬁnition Estimate Est. method
 Rate of admission and discharge per bed 0.17 day−1 MSHd
N Number  of beds in the ICU 16 MSHd
a Fraction of admitted patients with prior exposure to antimicrobials 0.6 MSHe
m  Fraction of patients admitted colonized [0, 0.0188] See Methods
r1 Fraction of patients admitted colonized with ceftazidime-resistant isolates 0.07 see Methods
r2 Fraction of patients admitted colonized with ciproﬂoxacin-resistant isolates 0.25 see Methods
r3 Fraction of patients admitted colonized with meropenem-resistant isolates 0.07 see Methods
ˇ  Transmission rate [0.0095, 0.0175] day−1 patient−1 see Methods
 Rate  that colonized patients become infected 0.14 day−1 Boyer et al. (2011)
0 Rate of beginning an antimicrobial treatment day−1; less after the ASP see Result 1
1 Rate of ending an antimicrobial treatment 0.087 day−1 (before ASP) MSHe
0.125 day−1 (after ASP) MSHe
2 Rate of ending antimicrobial treatment given a treatment failure 0.067 day−1 MSHe
1 Rate of emergence of ceftazadime resistance 0.025 day−1 Juan et al. (2005)
2 Rate of emergence of ciproﬂoxacin resistance 0.033 day−1 Juan et al. (2005)
3 Rate of emergence of meropenem resistance 0.024 day−1 Juan et al. (2005)
ω1 Fraction of colonized patients prescribed ceftazidime Less after the ASP see Result 3
ω2 Fraction of colonized patients prescribed ciproﬂoxacin Less after the ASP see Result 3
ω3 Fraction of colonized patients prescribed meropenem Less after the ASP see Result 3
˛1 Probability of prescribing ceftazidime to a patient with a P. aeruginosa infection 0.4 MSHe
˛2 Probability of prescribing ciproﬂoxacin to a patient with a P. aeruginosa infection 0.1 MSHe
˛3 Probability of prescribing meropenem to a patient with a P. aeruginosa infection 0.1 MSHe
˛ Probability of prescribing piperacillin-tazobactam to a patient with a P. aeruginosa infection 0.4 MSHe
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SHd, a parameter estimate speciﬁc to the MSH  ICU estimated from data; MSH
tewardship program.
ethod for estimating r1, r2 and r3
The model predicted fraction of ﬁrst isolates that are resis-
ant, Ri/C, is greater than or equal to the fraction of resistant
solates amongst patients admitted colonized, ri, because the math-
matical model assumes that in the ICU susceptible clones of P.
eruginosa may  become resistant, but not that resistant clones
ay  become susceptible. The minimum prevalence of resistance
n the MSH  data is 0.07 for ceftazidime, 0.25 for ciproﬂoxacin and
.07 for meropenem. If r1, r2 and r3 exceed these values then the
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he  stewardship program was  enacted.rameter speciﬁc to MSH  and estimated from expert opinion; ASP, antimicrobial
parameterized model cannot achieve these minima no matter how
an antimicrobial stewardship program is implemented. Therefore,
r1, r2 and r3 were estimated as 0.07, 0.25 and 0.07.
Method for estimating m and ˇGiven that m is the fraction of patients admitted colonized and
 ˇ is the transmission rate, if either of these values are too large
then the model predicted number of patients colonized will greatly
exceed the corresponding reported values. These parameters, m
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Fig. 3. Combinations of  ˇ and m parameter values (grey shading) such that the con-
ditions described in Eq. (6) are met. From the MSH  data the mean number of patients
colonized and colonized with resistant ﬁrst isolates are C+ = 25.5, R+1 = 8.75, R+2 =
12.5,  R+3 = 7.5 (before the antimicrobial stewardship program) and C− = 19, R−1 =
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1stimated as described in Table 2. These results demonstrate that the estimated
alue of m must be between 0 and 0.0188, that the estimated value of  ˇ must be
etween 0.0095 and 0.0175.
nd ˇ, also determine the model predicted number of patients col-
nized with resistant P. aeruginosa,  and if m is too large relative
o ˇ, the predicted number of patients colonized with resistant
. aeruginosa will be too few. We  have not yet estimated the
nknown parameters related to antimicrobial stewardship (0
nd ωi), however, for any m and ˇ, the minimum and maximum
odel predictions are determined by considering the two possi-
le extremes in antimicrobial stewardship. We  identify feasible
ombinations of  ˇ and m by requiring that the range of the model
redictions includes the mean values reported in the MSH  data,
oth before and after the antimicrobial stewardship program.
Formally, let C− and R−
i
denote the minimum model predic-
ions where these are determined by setting 0 = 0, and let C+
nd R+
i
denote the maximum model predictions where these are
etermined by letting 0→ ∞ and by setting ω1 = ω2 = ω3 = 1/3 (this
ssumes that the maximum fractions of treated patients prescribed
ach antimicrobial are equal; see also assumption (viii) in Table 1).
hen, feasible combinations of  ˇ and m must satisfy the conditions,
C− ≤ C− < C+ ≤ C+ and,
R−
i
≤ R−i < R
+
i ≤ R+i for all i.
(6)
sing this estimation method, we determine that the feasible
arameter estimates are the combinations of m and  ˇ shown in
ig. 3. The results shown in Fig. 3 imply that necessary (but not
ufﬁcient) conditions are 0.0095 ≤  ˇ ≤ 0.0175 and 0 ≤ m ≤ 0.0188
Table 2).
esults
Having derived an appropriate model and estimated all the
odel parameters except those related to antimicrobial steward-
hip, we now analyze the mathematical model to understand how
hanges in antimicrobial stewardship translate into changes in the
redicted number of patients colonized and colonized with resis-
ant P. aeruginosa.  Our analysis produces three main results.
. Fewer patients were treated after the implementation of the antimi-
crobial stewardship program To show that fewer patients (FP)s 4 (2012) 203–210 207
were prescribed antimicrobials after the implementation of the
antimicrobial stewardship program, consider the expression for
C, the model predicted number of patients colonized during a
six-month period (Eq. (2)). The dependence of this quantity on
antimicrobial stewardship is via the possible dependence of the
number of patients susceptible to colonization, XˆT + XˆA, and the
colonization pressure, Sˆ + Rˆ, at equilibrium, on the parameters
related to antimicrobial stewardship, 0, 1 and ωi. By adding
Eqs. (A.2) and (A.3) and Eqs. (A.4)–(A.14) and setting the results
equal to zero, we have the following system of equations,
a(1 − m)N − ˇ(XˆT + XˆA)(Sˆ + Rˆ) + 0Xˆ× − (XˆT + XˆA) = 0, (7)
mN + ˇ(XˆA + XˆT )(Sˆ + Rˆ) − (Sˆ + Rˆ) = 0, (8)
and in setting Eq. (A.1) equal to zero, we have that,
Xˆ× = (1 − a)(1 − m)N
0 + 
.  (9)
Eqs. (7) and (8) are a system of two equations that can be solved
for XˆT + XˆA and Sˆ + Rˆ, where doing so, reveals that the only
parameter related to antimicrobial stewardship appearing in
these expressions is 0, the parameter characterizing the fraction
of uninfected patients prescribed antimicrobials. Importantly,
the other parameters related to antimicrobial stewardship, the
types of antimicrobials prescribed to uninfected patients that are
treated, ωi, and the average duration of treatment, 1/1, do not
appear in Eqs. (7)–(9).
The result that only treating fewer patients (FP), by way of
decreasing 0, can reduce the number of patients colonized
arises as a consequence of the model assumptions (i) and (ii)
(Table 1). Both these assumptions were made because these
accurately reﬂect the best current understanding of P. aeruginosa
ecology in the ICU. Assumption (i) states that upon ending treat-
ment, patients or the patient’s immediate environment remains
colonized, and as a consequence, the rate of ending treatment, 1,
does not affect colonization pressure, S + R. Assumption (ii) states
that all P. aeruginosa clones are equally transmissible. If this were
not the case, C,  (Eq. (2)) would depend on the number of patients
colonized with clones of different antimicrobial susceptibilities,
and not simply the sum, S + R. Even under assumption (ii), the
number of patients carrying P. aeruginosa clones susceptible to
all three antimicrobials, S, and resistant to at least one antimicro-
bial, R, depends on 1 and ωi, however, notably, their sum, S + R,
does not. Therefore, since the data at MSH  reports that fewer
patients were colonized after the implementation of the antimi-
crobial stewardship program than were before (19 = C− < C+ =
25.5) we conclude that fewer patients (FP) were treated after the
antimicrobial stewardship program was  implemented.
2. Shortening the duration of treatment had a negligible effect Given
the parameter values estimated in Table 2, reducing the dura-
tion of treatment (SD) from 11–12 to 8 days had almost no effect
on P. aeruginosa resistance. To understand why, consider that
the chance of resistance to ciproﬂoxacin emerging is 27.5% for
an 11.5 day treatment versus 21% for an 8 day treatment. How-
ever, the chance of resistance emerging before discharge from
the ICU is reduced only from 11% to 10%; and the chance of
resistance to ceftazidime and meropenem emerging before dis-
charge is reduced by even less (see Appendix A for more details).
This suggests, ﬁrstly, that for ICUs with longer average durations
of stay, reducing the duration of antimicrobial treatment might
have a more noticeable effect, and secondly, that the effects due
to reducing the duration of antimicrobial treatment may  not be
noticeable in the ICU, but noticeable at the level of the entire
hospital (with the proviso that patients in other wards are gen-
erally less susceptible to P. aeruginosa colonization). Finally, we
208 A. Hurford et al. / Epidemics 4 (2012) 203–210
0 20 40
0
5
10
15
20
No. colonized
N
o.
 C
ef
t−
R
0 20 40
0
5
10
15
20
25
No. colonized
N
o.
 C
ip
ro
−R
0 20 40
0
5
10
15
No. colonized
N
o.
 M
er
o−
R
0 20 40
0
5
10
15
20
No. colonized
N
o.
 C
ef
t−
R
0 20 40
0
5
10
15
20
25
N
o.
 C
ip
ro
−R
No. colonized
0 20 40
0
5
10
15
No. colonized
N
o.
 M
er
o−
R
A
B
Fig. 4. Comparison of the data before (circles) and after (triangles) the antimicrobial stewardship program with the model predictions (dashed lines) under the assumptions
that  after the implementation of the antimicrobial stewardship program: (A) fewer patients were treated (FP only); and (B) fewer patients were treated and alternative
types of treatments were used (FP and AT both). The solid black line connects the mean values before and after the antimicrobial stewardship program for the MSH  data.
In  (A), the slope of the dashed curves (model predictions) is never as steep as the slope of the solid black line (data), whereas in (B) the slopes of these curves show
better  agreement. For (A), the dashed curves were generated by allowing 0 to range between 0 and 1 with ωi = 0.2 for all i. For (B), ωi changes along with 0 (speciﬁcally,
ω e rang
w  at MS
t ey reg
3i(0) = 0.003exp(300)/(0.3 + 0.001(exp(300) − 1)). The grey shaded areas show th
ith  resistant ﬁrst isolates before and after the antimicrobial stewardship program
he  corresponding  ˇ values were the mean of the lower and upper bounds of the gr
note that assumptions (v) and (ix) (Table 1) are necessary for this
conclusion to hold.
. Fewer antipseudomonal antimicrobials were prescribed after the
implementation of the antimicrobial stewardship program Pre-
scribing antimicrobials to fewer patients (FP) not only leads to a
decrease in the number of patients colonized, it also produces a
decrease in the number of patients colonized with resistant ﬁrst
isolates. We  numerically solved the system of Eqs. (A.1)–(A.14)
to evaluate Eqs. (2) and (3) for a range of different 0 val-
ues. Fig. 4A shows that no matter which values of m and ˇ
are chosen, if only fewer patients are prescribed antimicrobials
after the implementation of the antimicrobial stewardship pro-
gram, then the model predicts more patients colonized with
resistant P. aeruginosa than was reported in the MSH  data. For
the numerical results shown in Fig. 4A, the types of treatment
(AT) are unchanged (ωi = 0.2 for all i) as the shift to treating
fewer patients occurs. Alternatively in Fig. 4B, the dual effect
of antimicrobial stewardship is to treat fewer patients and to
use antipseudomonal antimicrobials less often (FP and AT) and
Fig. 4B shows a better agreement between the model predic-
tions and the data from MSH. To summarize, given the decrease
in the mean number of patients colonized after the antimi-
crobial stewardship program, the decrease in the number of
patients colonized with resistant ﬁrst isolates reported at MSH
is too large to be explained by treating fewer patients alone
(FP only).e in the reported number of patients colonized and the number of patients colonized
H. The different dashed lines show m = 0.001, 0.0025, 0.005, 0.01 and 0.015, where
ion of Fig. 3 for each m.
Aspects of an antimicrobial stewardship program which would
most substantially decrease resistance
In addition to identifying the aspects of the antimicrobial
stewardship program most responsible for the changes reported
at MSH, we identify which aspect of antimicrobial stewardship
would contribute most substantially to decreasing the prevalence
of resistance if any one intervention could be implemented. We
numerically solved Eqs. (A.1)–(A.14) for reasonable parameter val-
ues and determined that the most substantial reductions in the
number of patients colonized with resistant ﬁrst isolates would be
achieved when the fraction of patients prescribed antimicrobials
(FP) is initially close to one and is decreased (Fig. 5).
Discussion
The past decade has seen an increasing emphasis on patient
safety in clinical care settings (Kohn et al., 2000). The recognition
of the substantial costs and adverse health outcomes associated
with hospital-acquired infections and preventable medical errors
has led to restructuring of fee schedules by the US  Centers for Medi-
care/Medicaid Service and has spawned antimicrobial stewardship
programs and other innovative efforts by clinicians seeking to mini-
mize such outcomes (Centers for Medicare/Medicaid Services, HHS,
2011).  We  utilized primary data from an antimicrobial steward-
ship program at a major North American teaching hospital to build
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utewardship program are reducing the fraction of uninfected patients prescribed a
he  type of antimicrobials prescribed to treated patients (AT). Parameters used wer
3 = 0.2 (except for the panels where these parameters were varied) and otherwise
nd parameterize a mathematical model of the transmission of P.
eruginosa in an intensive care setting. Our analysis showed that
he best explanation for the reported decrease in the prevalence
f resistance was the reduced use of antimicrobials in uninfected
atients (FP) and the reduced use of antipseudomonal antimicro-
ial agents (AT). It is, of course, possible that the use of other agents
e.g. sulfas, ceftriaxone, and penicillins other than antipseudomonal
enicillins) has enhanced resistance to these other agents but in
he intensive care context the preservation of susceptibility in P.
eruginosa is likely to have been a more important achievement.
Our model makes assumptions about both antimicrobial uti-
ization and the ecology of the ICU. We  are unable to evaluate
he possibility that contemporaneous changes in infection con-
rol practices occurring as part of a ‘culture of safety’ might have
aused the reported declines in resistant P. aeruginosa infections, for
xample via improved hand hygiene or improved compliance with
ontact precautions in those caring for patients with ARO. While we
annot rule out this possibility, we have no reason to believe that
uch dramatic improvements in infection control occurred at this
ime, whereas we know that measures to improve antimicrobial
tewardship were undertaken.
Other model assumptions were made to promote either bio-
ogical realism or model simplicity but we do not believe that
hese assumptions strongly inﬂuence our conclusions. We  assumed
hat antimicrobial use did not eradicate P. aeruginosa coloniza-
ion, which is concordant with the available literature suggesting
hat long-term decolonization of individuals with carriage of gram-
egative ARO is difﬁcult, though recovery of microbes has been
ransiently suppressed with selective digestive decontamination
for example, Saidel-Odes et al. (2012)). However, even if antimi-
robials do eradicate colonization, this would occur towards the
nd of a patient’s stay and would contribute minimally to reducing
he risk of healthcare worker contamination.
While novel in its evaluation of an antimicrobial stewardship
rogram, our model follows numerous other studies that have
mployed mathematical models to gain similar insights into the
pidemiology of antimicrobial resistance (Bonhoeffer et al., 1997;
ustin et al., 1999; Lipsitch et al., 2000; Smith et al., 2004; Bootsma
t al., 2006; Boldin et al., 2007; D’Agata et al., 2009). The ability of
uch models to explicitly consider the non-independence of infec-
ions that constitutes a key attribute of communicable diseases
nd provides an important and distinct advantage in the explo-
ation of data when compared, for example, to the interrupted
ime series analyses that have been typically employed in the eval-
ation of stewardship programs (Ansari et al., 2003; Peto et al.,robials (FP), shortening the duration of antimicrobial treatment (SD), and altering
.0112 day−1 patient−1, m = 0.0019, 1 = 0.087 day−1, 0 = 0.8, ω1 = 0.05, ω2 = 0.2 and
en by Table 2.
2008; Yong et al., 2010). Mathematical models can thus provide
a platform that allows synthesis of available data on stewardship
programs and exploration of mechanistic aspects of the programs
most likely to have resulted in the observed changes in the risk of
infection with resistant pathogens. To the best of our knowledge,
the application of mathematical modeling tools to the evaluation of
antimicrobial stewardship programs has been extremely limited to
date.
Conclusions
A relatively simple model that incorporated several different
attributes of the stewardship program (i.e., diminished administra-
tion of antimicrobials to uninfected individuals; limited duration
of therapy; reduced use of antipseudomonal antimicrobials) was
successful in reproducing observed declines in the mean risk of
colonization or infection with resistant P. aeruginosa before and
after the implementation of an antimicrobial stewardship program.
Using this approach we were able to determine the effects of the
different elements of the antimicrobial stewardship program and to
identify reduced prescribing of antimicrobials (FP) as the attribute
of an antimicrobial stewardship program that would most sub-
stantially reduce antimicrobial resistance in P. aeruginosa in the
future.
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